Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial

D Molina-Morant; M L Fernández; P Bosch-Nicolau; E Sulleiro; M Bangher; F Salvador; A Sanchez-Montalva; A L P Ribeiro; A M B de Paula; S Eloi; R Correa-Oliveira; J C Villar; S Sosa-Estani; I Molina

doi:10.1186/s13063-023-07659-5

Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial

Trials. 2023 Nov 14;24(1):726. doi: 10.1186/s13063-023-07659-5.

Authors

D Molina-Morant¹, M L Fernández², P Bosch-Nicolau¹, E Sulleiro³, M Bangher⁴, F Salvador¹, A Sanchez-Montalva¹, A L P Ribeiro⁵, A M B de Paula⁶, S Eloi^{7

8}, R Correa-Oliveira⁹, J C Villar^{10

11}, S Sosa-Estani^{12

13}, I Molina¹⁴

Affiliations

¹ Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, P° Vall d'Hebron 119, Edifici Mediterrània, VHIR, 08035, Barcelona, Spain.
² Departamento de Clínica, Patología y Tratamiento, Instituto Nacional de Parasitología Dr. Mario Fatala Chaben, Ministerio de Salud y Desarrollo Social, Buenos Aires, Argentina.
³ Microbiology Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain.
⁴ Instituto de Cardiología de Corrientes Juana Francisca Cabral (Argentina), Corrientes, Argentina.
⁵ Programa de Pós-Graduação Infectologia E Medicina Tropical, Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
⁶ Laboratory of Health Science, Postgraduate Program in Health Sciences, Universidade Estadual de Montes Claros (Unimontes), Montes Claros, MG, Brazil.
⁷ Programa de Pós-Graduação Em Patologia, Departamento de Propedêutica Complementar, Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
⁸ Faculdade de Medicina da Universidade José Do Rosário Vellano, Belo Horizonte, Brazil.
⁹ René Rachou Institute, Oswaldo Cruz Foundation, Belo Horizonte, Brazil.
¹⁰ Faculty of Health Sciences, Universidad Autónoma de Bucaramanga and Research Department, Bucaramanga, Colombia.
¹¹ Fundación Cardioinfantil - Instituto de Cardiología, Bogotá, Colombia.
¹² Chagas Clinical Program, Drugs for Neglected Disease Initiative (DNDi), Geneva, Switzerland.
¹³ Epidemiology and Public Health Research Center, CONICET, Buenos Aires, Argentina.
¹⁴ Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, P° Vall d'Hebron 119, Edifici Mediterrània, VHIR, 08035, Barcelona, Spain. imolina@vhebron.net.

No abstract available

Publication types

Published Erratum